Evaluating Heart Risk: The Role of Calcium Scans in Statin Decisions
Recent studies highlight how coronary artery calcium scans can inform statin treatment decisions, especially in borderline risk cases.
August 26, 2026
Finance
Financial news, markets, and business updates
Emerging Cardio Drugs: A Focus on Lipoprotein(a) Targets
Pharmaceutical giants are poised to unveil data on new cardiovascular drugs targeting lipoprotein(a), marking a potential breakthrough in treatment.
August 26, 2026
Rising Health Care Costs Challenge Large Employers
Recent findings highlight the surprising surge in health care costs for major companies, prompting scrutiny and reevaluation of existing healthcare strategies.
August 26, 2026
U.S. Employers Scale Back GLP-1 Coverage as Massachusetts Biotech Jobs Decline
A notable drop in GLP-1 drug coverage among U.S. employers coincides with a decline in Massachusetts' biotech workforce, highlighting industry challenges.
August 26, 2026
Emerging Treatments Target Genetic Heart Disease Risk Factors
A new wave of drug trials aims to tackle genetic heart disease risk factors, particularly targeting Lp(a), with major implications for the pharmaceutical market.
August 26, 2026
Shifting the Narrative: Profit Motive as a Driver in Women's Health Research
Addressing women's health disparities could generate significant economic gains, with estimates suggesting a $1 trillion boost worldwide by 2040.
August 26, 2026
Roche's U.S. Investment and Ongoing Estrogen Patch Shortages Highlight Industry Challenges
Roche's significant investment in the U.S. coincides with heightened demand for estrogen patches, now facing severe production challenges.
August 21, 2026
Assessing Drug Prescribing Patterns in Cancer Care
Recent observations suggest cancer patients might be receiving unwarranted high doses and lengthy treatments of costly medications.
August 21, 2026
Merck's Ebola Vaccine Rollout as Outbreak Intensifies in DRC
With Ebola cases rising sharply in the DRC, Merck's vaccine is set for deployment to enhance response efforts, including a significant clinical trial.
August 21, 2026
Emerging Focal Therapy for Prostate Cancer: A Shift in Treatment Paradigms
Focal therapy is increasingly considered in prostate cancer treatment, offering a targeted approach with fewer side effects than traditional methods.
August 21, 2026
Significant Milestones in Cancer Treatment: Merck and Moderna's mRNA Breakthrough
The recent success of Merck and Moderna's personalized mRNA cancer therapy marks a pivotal moment in cancer treatment advancements.
August 20, 2026
New Initiatives from STAT Aim to Restore Trust in Science Reporting
STAT launches strategic roles and initiatives to combat misinformation and rebuild public trust in science, led by seasoned journalist Nicholas Florko.
August 19, 2026
Regeneron Gains FDA Approval for Pasatru, a Breakthrough for FOP Patients
Regeneron's new drug, Pasatru, is approved to treat fibrodysplasia ossificans progressiva, aiming to significantly improve patient outcomes.
August 19, 2026
American Cancer Society Discontinues Fundraiser Tied to Alcohol Industry
The ACS has canceled its Wine and Spirits Industry Gala, reconsidering fundraising methods amid concerns over conflicts with its mission.
August 19, 2026
Epic's Annual Meeting: Key Developments and Highlights on AI in Healthcare
Epic's annual meeting revealed new customer partnerships and engaging presentations, but left attendees wanting more on AI developments.
August 19, 2026
Moderna and Merck's mRNA Cancer Vaccine Shows Promise in Melanoma Trial
Moderna and Merck announced positive findings from a late-stage melanoma trial using a personalized mRNA vaccine, potentially transforming cancer treatment.
August 19, 2026
Elisabeth Marnik: From Vaccine Skepticism to Advocate for Science Communication
Elisabeth Marnik transformed her life by embracing vaccinations, using her own journey to advocate for science communication and understanding diverse perspectives.
August 19, 2026
Experts Critique Huidagene's Gene Editing Trial Following Tragedy
Experts weigh in on the controversial gene editing trial by Huidagene, offering mixed reviews of the science behind it after a tragic incident.
August 19, 2026
FTC Investigates Epic Systems' Business Practices for Antitrust Violations
The FTC is investigating Epic Systems for potential antitrust violations related to its market dominance and employment contracts.
August 14, 2026
Navigating New Parenthood: Insights from a Pediatrician's Perspective
Every new parent grapples with a mix of emotions and decisions, often feeling overwhelmed. A pediatrician shares valuable insights from years of experience.
August 14, 2026